341 related articles for article (PubMed ID: 26885361)
1. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.
Tack LJ; Craen M; Dhondt K; Vanden Bossche H; Laridaen J; Cools M
Biol Sex Differ; 2016; 7():14. PubMed ID: 26885361
[TBL] [Abstract][Full Text] [Related]
2. Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents.
Tack LJW; Heyse R; Craen M; Dhondt K; Bossche HV; Laridaen J; Cools M
J Sex Med; 2017 May; 14(5):747-757. PubMed ID: 28499525
[TBL] [Abstract][Full Text] [Related]
3. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
Vita R; Settineri S; Liotta M; Benvenga S; Trimarchi F
Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
[TBL] [Abstract][Full Text] [Related]
4. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
Stoffers IE; de Vries MC; Hannema SE
J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
[TBL] [Abstract][Full Text] [Related]
5. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
7. Proandrogenic and Antiandrogenic Progestins in Transgender Youth: Differential Effects on Body Composition and Bone Metabolism.
Tack LJW; Craen M; Lapauw B; Goemaere S; Toye K; Kaufman JM; Vandewalle S; T'Sjoen G; Zmierczak HG; Cools M
J Clin Endocrinol Metab; 2018 Jun; 103(6):2147-2156. PubMed ID: 29672753
[TBL] [Abstract][Full Text] [Related]
8. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
[TBL] [Abstract][Full Text] [Related]
9. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Smith KP; Madison CM; Milne NM
Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
[TBL] [Abstract][Full Text] [Related]
10. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
11. Long-term profile of a new progestin.
Lippman J
Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
[TBL] [Abstract][Full Text] [Related]
12. Effects of three different testosterone formulations in female-to-male transsexual persons.
Pelusi C; Costantino A; Martelli V; Lambertini M; Bazzocchi A; Ponti F; Battista G; Venturoli S; Meriggiola MC
J Sex Med; 2014 Dec; 11(12):3002-11. PubMed ID: 25250780
[TBL] [Abstract][Full Text] [Related]
13. Restovar--new low-dose, combined, oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy.
Cullberg G; Adelgaard J; Andersen JN; Andersen ES; Berg H; Bergink EW; Buhl G; Pedersen JH; Poulsen L
Contracept Deliv Syst; 1984 Apr; 5(2):97-104. PubMed ID: 12266201
[TBL] [Abstract][Full Text] [Related]
14. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
Nader S; Riad-Gabriel MG; Saad MF
J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
[TBL] [Abstract][Full Text] [Related]
15. Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey.
Karakılıç Özturan E; Öztürk AP; Baş F; Erdoğdu AB; Kaptan S; Kardelen Al AD; Poyrazoğlu Ş; Yıldız M; Direk N; Yüksel Ş; Darendeliler F
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):276-284. PubMed ID: 36987788
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
Bowles SM; Mills RJ
Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
[TBL] [Abstract][Full Text] [Related]
17. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
18. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of youth with gender dysphoria in Vancouver.
Khatchadourian K; Amed S; Metzger DL
J Pediatr; 2014 Apr; 164(4):906-11. PubMed ID: 24315505
[TBL] [Abstract][Full Text] [Related]
20. Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria.
Jarin J; Pine-Twaddell E; Trotman G; Stevens J; Conard LA; Tefera E; Gomez-Lobo V
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
